Alnylam Pharmaceuticals, Inc. Reports Inducement Grant to New Chief Financial Officer

May 12, 2017  CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that it has granted stock options to

Read more

Nolato Completes Acquisition of Treff AG

October 03, 2016  TOREKOV, Sweden–(BUSINESS WIRE)–Regulatory News: Nolato (STO:NOLAB) has completed its acquisition of Swiss company Treff AG. The final purchase price for the

Read more

New FDA Regulation Allows Dermatologists to Customize Patient Prescriptions

August 23, 2016  POMPANO BEACH, Fla.–(BUSINESS WIRE)–Prescriber’s Choice, a Florida-based pharmaceutical company, has created a new model for dermatological prescriptions where medications can be

Read more

Tokai Pharmaceuticals Announces Reduction in Force

July 29, 2016  BOSTON–(BUSINESS WIRE)–Tokai Pharmaceuticals Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally

Read more